Turkish Adaptation of the CSQ-VR
ConditionHealthy Volunteers
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-30
SponsorAbant Izzet Baysal University
About this trial
The Cybersickness in Virtual Reality Questionnaire (CSQ-VR) is a tool designed to measure the presence and intensity of cybersickness symptoms experienced in VR. The CSQ-VR is an adapted and improved version of the Cybersickness section of the Virtual Reality Neuroscience Questionnaire (VRNQ). The aim of this study is to examine the validity and reliability of the Turkish version of the CSQ-VR.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Voluntary agreement to participate in the study
Ability to stand and walk independently
Disqualifiers
Presence of amblyopia, strabismus, or pathologies impairing focus, depth perception, or normal 3D vision
Failure on the butterfly test of the Titmus stereotest
Trial population
Healthy volunteers aged 18-30 years with independent standing and walking ability will be recruited.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
42 Participants
are grouped into 1 trial groupGroup A: Healthy volunteer
Trial outcomes
Primary outcomes
1
Cybersickness in Virtual Reality Questionnaire
It is a tool designed to measure the presence and severity of cybersickness symptoms experienced in VR
Time frame
Immediately after a single VR session (~1 hour)Secondary outcomes
1
Simulator Sickness Questionnaire
The Simulator Sickness Questionnaire evaluates 16 symptoms such as eye strain, nausea, sweating, and headache, each rated on four severity levels (none, slight, moderate, and severe).
Time frame
Immediately after a single VR session (~1 hour)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov